Drug Eluting Stent System Market, Global Outlook and Forecast 2023-2032
It is used to treat narrowed or blocked blood vessels in the heart by reflowing blood through the blood vessels with an inflated balloon. A coronary stent is then placed into the vessel to ensure it remains open. Two types of stents are available, one that is coated with a drug to reduce the risk of future blockages (drug-eluting stents) and one that is uncoated (bare-metal stents).
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Stent System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Stent System. This report contains market size and forecasts of Drug Eluting Stent System in global, including the following market information:
Global Drug Eluting Stent System Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Drug Eluting Stent System Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Drug Eluting Stent System companies in 2022 (%)
The global Drug Eluting Stent System market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
High Molecular Polymer Carrier Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Drug Eluting Stent System include Medtronic, Boston Scientific, Biosensors, Terumo, MicroPort, Lepu Medical, B.Braun, Atrium Medical and SINOMED, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Drug Eluting Stent System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Eluting Stent System Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Drug Eluting Stent System Market Segment Percentages, by Type, 2022 (%)
High Molecular Polymer Carrier
No High Molecular Polymer Carrier
Global Drug Eluting Stent System Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Drug Eluting Stent System Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Global Drug Eluting Stent System Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Drug Eluting Stent System Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug Eluting Stent System revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Drug Eluting Stent System revenues share in global market, 2022 (%)
Key companies Drug Eluting Stent System sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Drug Eluting Stent System sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Boston Scientific
Biosensors
Terumo
MicroPort
Lepu Medical
B.Braun
Atrium Medical
SINOMED
LBC
Essen Technology
Yinyi Biotech CO.,LTD.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drug Eluting Stent System, market overview.
Chapter 2: Global Drug Eluting Stent System market size in revenue and volume.
Chapter 3: Detailed analysis of Drug Eluting Stent System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drug Eluting Stent System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Drug Eluting Stent System capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
